These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23880200)

  • 1. Gut microbiota: an environmental risk factor for cardiovascular disease.
    Stock J
    Atherosclerosis; 2013 Aug; 229(2):440-2. PubMed ID: 23880200
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
    Wang Z; Klipfell E; Bennett BJ; Koeth R; Levison BS; Dugar B; Feldstein AE; Britt EB; Fu X; Chung YM; Wu Y; Schauer P; Smith JD; Allayee H; Tang WH; DiDonato JA; Lusis AJ; Hazen SL
    Nature; 2011 Apr; 472(7341):57-63. PubMed ID: 21475195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
    Ussher JR; Lopaschuk GD; Arduini A
    Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
    Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
    Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary modification of the microbiome affects risk for cardiovascular disease.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2013 Jun; 16(3):241-4. PubMed ID: 23656565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis.
    Li D; Kirsop J; Tang WH
    Curr Diab Rep; 2015 Sep; 15(9):63. PubMed ID: 26208694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Microbiota in Cardiovascular Risk: Focus on Trimethylamine Oxide.
    Al-Rubaye H; Perfetti G; Kaski JC
    Curr Probl Cardiol; 2019 Jun; 44(6):182-196. PubMed ID: 30482503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.
    Brown JM; Hazen SL
    Annu Rev Med; 2015; 66():343-59. PubMed ID: 25587655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological considerations for the identification of choline and carnitine-degrading bacteria in the gut.
    Jameson E; Quareshy M; Chen Y
    Methods; 2018 Oct; 149():42-48. PubMed ID: 29684641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
    Tang WH; Hazen SL
    Transl Res; 2017 Jan; 179():108-115. PubMed ID: 27490453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota produced trimethylamine-N-oxide can increase the risk of cardiovascular disease.
    Khan MS; Bawany FI; Khan A
    J Pak Med Assoc; 2014 Apr; 64(4):488. PubMed ID: 24864657
    [No Abstract]   [Full Text] [Related]  

  • 12. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).
    Zhu Y; Shui X; Liang Z; Huang Z; Qi Y; He Y; Chen C; Luo H; Lei W
    Int J Mol Med; 2020 Sep; 46(3):936-948. PubMed ID: 32705240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for cardiovascular disease: a cautionary tale of diet-microbiome interactions.
    Miller MJ
    J Am Coll Nutr; 2013; 32(2):75-8. PubMed ID: 24015714
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet.
    Moraes C; Fouque D; Amaral AC; Mafra D
    J Ren Nutr; 2015 Nov; 25(6):459-65. PubMed ID: 26235933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut flora, diet and intestinal metabolism on cardiovascular risk.
    Bhatnagar D
    Curr Opin Lipidol; 2015 Apr; 26(2):148-9. PubMed ID: 25756810
    [No Abstract]   [Full Text] [Related]  

  • 17. [The relationship between gut microbiota and cardiovascular diseases].
    Gerardi V; Del Zompo F; D'Aversa F; Gasbarrini A
    G Ital Cardiol (Rome); 2016 Jan; 17(1):11-4. PubMed ID: 26901254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease: the diet-microbe morbid union.
    Rak K; Rader DJ
    Nature; 2011 Apr; 472(7341):40-1. PubMed ID: 21475185
    [No Abstract]   [Full Text] [Related]  

  • 19. Gut microbiome as a novel cardiovascular therapeutic target.
    Singh V; Yeoh BS; Vijay-Kumar M
    Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Are Missing Parts in the Research Story of Trimethylamine-N-oxide (TMAO)?
    He Z; Chen ZY
    J Agric Food Chem; 2017 Jul; 65(26):5227-5228. PubMed ID: 28650144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.